Opioid trail: Tracking contributions to opioid use disorder from host genetics to the gut microbiome

Abstract

Opioid use disorder (OUD) is a worldwide public health crisis with few effective treatment options. Traditional genetics and neuroscience approaches have provided knowledge about biological mechanisms that contribute to OUD-related phenotypes, but the complexity and magnitude of effects in the brain and body remain poorly understood. The gut-brain axis has emerged as a promising target for future therapeutics for several psychiatric conditions, so characterizing the relationship between host genetics and the gut microbiome in the context of OUD will be essential for development of novel treatments. In this review, we describe evidence that interactions between host genetics, the gut microbiome, and immune signaling likely play a key role in mediating opioid-related phenotypes. Studies in humans and model organisms consistently demonstrated that genetic background is a major determinant of gut microbiome composition. Furthermore, the gut microbiome is susceptible to environmental influences such as opioid exposure. Additional work focused on gene by microbiome interactions will be necessary to gain improved understanding of their effects on OUD-related behaviors.

Keywords: Behavioral genetics; Genetic mapping; Gut-brain axis; Microbiota; Opioid dependence; Rodent genetics.

Figure 1:

Overview of relationships between host genetics, the gut microbiome, and neural signaling that contribute to OUD. Created with BioRender.com.

Figure 2:

Overview of circuits mediating addiction-related behaviors. Red indicates dopamine, blue indicates GABA, and green indicates glutamate. Created with BioRender.com. Abbreviations: AMG, amygdala; HIPPO, hippocampus; NAc, Nucleus accumbens; PAG, periaqueductal grey, PFC, prefrontal cortex; VTA, ventral tegmental area